Maravai LifeSciences Holdings, Inc.
Simbols: MRVI
NASDAQ
8.87
USDTirgus cena šodien
-9.7422
P/E koeficients
-0.1333
PEG koeficients
1.18B
MRK Cap
- 0.00%
DIV ienesīgums
Maravai LifeSciences Holdings, Inc. Vadības struktūra
Informācija par vadību
Nosaukums | Tituls |
---|---|
Mr. William E. Martin III | Chief Executive Officer |
Ms. Christine Dolan | Executive Vice President & GM of Cygnus Technologies |
Mr. Kurt Oreshack | Executive Vice President, General Counsel & Secretary |
Mr. Andrew Burch | President of Nucleic Acid Production |
Ms. Debra Hart | Senior Director of Investor Relations |
Ms. Rebecca Buzzeo | Executive Vice President & Chief Commercial Officer |
Mr. Carl W. Hull | Co-Founder & Executive Chairman |
Mr. Kevin M. Herde | Executive Vice President & Chief Financial Officer |
Dr. Peter Michael Leddy Ph.D. | Executive Vice President & Chief Administrative Officer |
Dr. Kate E. Broderick Ph.D. | Chief Innovation Officer |
Līdzīgas akcijas
Jūs varētu arī interesēt:SRNE
Augstākā vadība:
- Dr. Scott Schaus
- Dr. Henry H. Ji P...
CMRA
Augstākā vadība:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
GUBRA.CO
Augstākā vadība:
- Ms. Trine Nygaard...
- Mr. Kristoffer R...
- Ms. Margit Bloch ...
T5O.DE
Augstākā vadība:
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
6826.HK
Augstākā vadība:
- Ms. Caixia Ren
- Mr. Ming King Ch...
- Ms. Min Tian
PPBT
Augstākā vadība:
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...